# Exagen (XGN) — Earnings

XGN · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/xgn/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.13 |
| EPS estimate | −$0.19 |
| EPS surprise | +32.08% |
| Revenue surprise | +12.03% |
| Revenue | $19.9M |
| Revenue estimate | $17.8M |
| Reported | Aug 4, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1274737/000127473726000048/exdx-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/9f108880-679a-fdca-cc27-15cbceb2be9c.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 4, 2026 | −$0.19 | −$0.13 | 32.08% | $17.8M | $19.9M |
| Q1 2026 | May 11, 2026 | −$0.23 | −$0.17 | 27.01% | $16.4M | $17.3M |
| Q4 2025 | Mar 10, 2026 | −$0.19 | −$0.20 | -5.43% | $16.6M | $16.6M |
| Q3 2025 | Nov 4, 2025 | −$0.16 | −$0.31 | -97.58% | $16.9M | $17.2M |
| Q2 2025 | Jul 29, 2025 | −$0.15 | −$0.21 | -40.00% | $16.3M | $17.2M |
| Q1 2025 | May 5, 2025 | −$0.20 | −$0.20 | 1.09% | $14.5M | $15.5M |
| Q4 2024 | Mar 11, 2025 | −$0.26 | −$0.20 | 21.88% | $13.6M | $13.7M |
| Q3 2024 | Nov 12, 2024 | −$0.29 | −$0.28 | 3.38% | $13.6M | $12.5M |
| Q2 2024 | Aug 5, 2024 | −$0.34 | −$0.16 | 52.94% | $13.1M | $15.1M |
| Q1 2024 | May 13, 2024 | −$0.36 | −$0.19 | 47.35% | $13.1M | $14.4M |
| Q4 2023 | Mar 18, 2024 | −$0.43 | −$0.31 | 27.99% | $11.6M | $13.8M |
| Q3 2023 | Nov 13, 2023 | −$0.47 | −$0.31 | 34.03% | $10.3M | $13.4M |
| Q2 2023 | Aug 7, 2023 | −$0.50 | −$0.28 | 43.51% | $10.9M | $14.1M |
| Q1 2023 | May 15, 2023 | −$0.56 | −$0.44 | 21.68% | $9.4M | $11.2M |
| Q4 2022 | Mar 20, 2023 | −$0.77 | −$0.83 | -8.20% | $8.7M | $12.8M |
| Q3 2022 | Nov 14, 2022 | −$0.77 | −$0.47 | 38.70% | $9.0M | $14.7M |
| Q2 2022 | Aug 4, 2022 | −$0.57 | −$0.78 | -37.06% | $12.0M | $9.0M |
| Q1 2022 | May 11, 2022 | −$0.61 | −$0.60 | 1.36% | $10.0M | $10.4M |
| Q4 2021 | Mar 22, 2022 | −$0.48 | −$0.42 | 12.59% | $11.7M | $12.7M |
| Q3 2021 | Nov 10, 2021 | −$0.46 | −$0.42 | 8.70% | $12.1M | $12.3M |

## Frequently Asked Questions

### When did Exagen (XGN) last report earnings?

Exagen last reported on Aug 4, 2026, covering fiscal Q2 2026.

### Did XGN beat earnings estimates?

Yes. Exagen reported EPS of −$0.13 for Q2 2026 against a −$0.19 estimate — a 32.08% beat.

### How much revenue did XGN report last quarter?

Exagen reported $19.9M in revenue for Q2 2026, against a consensus estimate of $17.8M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).